GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery

MLA

Universidad de Sevilla. Departamento de Química Orgánica y Farmacéutica, et al. GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367052174&authtype=sso&custid=ns315887.

APA

Universidad de Sevilla. Departamento de Química Orgánica y Farmacéutica, Carullo, G., Mazzotta, S., Vega Holm, M., Iglesias Guerra, F., Vega Pérez, J. M., Aiello, F., & Brizzi, A. (2021). GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Chicago

Universidad de Sevilla. Departamento de Química Orgánica y Farmacéutica, Gabriele Carullo, Sarah Mazzotta, Margarita Vega Holm, Fernando Iglesias Guerra, José Manuel Vega Pérez, Francesca Aiello, and Antonella Brizzi. 2021. “GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367052174&authtype=sso&custid=ns315887.